Powered By
Below is a listing of treatments and therapies for kidney disease. Click on one to read more information or connect with others currently using it.
Overview
Empaveli is approved by the U.S. Food and Drug Administration (FDA) to reduce proteinuria (excess protein in the urine) in certain types of kidney disease, specifically C3 glomerulopathy (C3G) and primary…
Overview
Fabhalta is approved by the U.S. Food and Drug Administration (FDA) to reduce proteinuria (excess protein in the urine) in adults with primary immunoglobulin A nephropathy (IgAN) who are at risk of rapid disease…
Overview
Filspari, approved by the U.S. Food and Drug Administration (FDA) in 2023, is prescribed to slow kidney function decline in adults with primary immunoglobulin A nephropathy (IgAN), a condition characterized by…
Overview
The Liposorber LA-15 System is approved by the U.S. Food and Drug Administration (FDA) as a humanitarian use device (HUD). It is used for adults and children with nephrotic syndrome (a condition causing protein…
Overview
Tarpeyo is approved by the U.S. Food and Drug Administration (FDA) to reduce the loss of kidney function in adults with primary immunoglobulin A nephropathy (IgAN) who are at risk for disease progression. To be…
Become a member to get even more
Join